Skip to main content

Relief from severe depression and suicidal ideation within hours: from synapses to symptoms

Wednesday, November 4, 2015 - 3:00pm to 4:00pm


Carlos Zarate, M.D.
Senior Investigator
National Institute of Mental Health


Dr. Zarate's current research focus is on developing novel medications for treatment-resistant depression and bipolar disorder. His areas of expertise include biological and pharmacological aspects of mood disorders in adults. Dr. Zarate's group conducts proof-of-concept studies utilizing novel compounds and biomarkers (magnetoencephalography [MEG] and polysomnography [PSG], positron emission tomography, functional MRI and magnetic resonance spectroscopy [MRS]) to identify potentially relevant drug targets and biosignatures of treatment response. A multidisciplinary translational research team conducts the research in the ETPB. In addition, the Branch provides training to develop the next generation of clinical translational researchers.

The page was last updated on Monday, August 31, 2015 - 3:24pm